Current price is more than the intrinsic value

Intrinsic Value

Stock has been generating better return on equity than bank FD

ROE vs FD rates

Stock doesn't offer attractive dividend returns

Dividend Returns

Good time to consider, as stock is not in overbought zone

Entry Point

Stock not in ASM/GSM lists and not a lot of promoter holding is pledged

No Red Flags

Motilal Oswal is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 1030 in its research report dated June 22, 2022.

Buy Ipca Laboratories; target of Rs 1030: Motilal Oswal

Broker’s Call: Ipca Laboratories (Buy)

Ipca Laboratories Ltd is quoting at Rs 879.1, up 1.55% on the day as on 12:49 IST on the NSE. The stock is down 14.37% in last one year as compared to a 0.06% jump in NIFTY and a 13.64% jump in the Nifty Metal index.

Ipca Laboratories Ltd up for third consecutive session

Here is what the charts say about the shares of Aarti Industries, HDFC AMC and IPCA Laboratories

Movers & Shakers: Stocks that will see action this week

Sharekhan recommended Hold rating on Ipca Laboratories with a target price of Rs 1080 in its research report dated May 25, 2022.

Hold Ipca Laboratories : target of Rs 1080: Sharekhan

Ipca is adding 1200 medical representatives with a focus on Ortho, Derma, and Cardiovascular therapies

IPCA Labs: Growth outlook primed by domestic business

Ipca Laboratories Ltd is quoting at Rs 912.3, down 0.43% on the day as on 13:19 IST on the NSE. The stock tumbled 10% in last one year as compared to a 5.86% rally in NIFTY and a 9.3% fall in the Nifty Metal index.

Ipca Laboratories Ltd slips for fifth straight session

Ipca Labs Q4 Review - Domestic Formulation On Robust Growth Path: Motilal Oswal

The company had posted a consolidated net profit after tax of Rs 161.34 crore in the same quarter previous fiscal, Ipca Laboratories said in a regulatory filing

Ipca Labs Q4 net profit declines 19% at Rs 130 crore on higher expenses

Ipca Labs Standalone March 2022 Net Sales at Rs 1,168.45 crore, up 12.25% Y-o-Y

IPCA Laboratories slumped 2.27% to Rs 954.90 after the company’s consolidated net profit fell 19.3% to Rs 130.23 crore despite of a 15.6% rise in net sales to Rs 1,289.10 crore in Q4 FY22 over Q4 FY21.

IPCA Lab slips after Q4 PAT declines 19% YoY to Rs 130 cr

Ipca Laboratories Limited is engaged in pharmaceuticals business. The Company is a manufacturer and supplier of over 10 active pharmaceutical ingredients (APIs).

IPCA Laboratories Ltd

IPCA Laboratories Ltd

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Buy Ipca Laboratories; target of Rs 1030: Motilal Oswal

Broker’s Call: Ipca Laboratories (Buy)

Ipca Laboratories Ltd up for third consecutive session

Movers & Shakers: Stocks that will see action this week

Hold Ipca Laboratories : target of Rs 1080: Sharekhan

IPCA Labs: Growth outlook primed by domestic business

Ipca Laboratories Ltd slips for fifth straight session

IPCA Laboratories Ltd

Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD ratesFixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend ReturnsA dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry PointHigh demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Buy Ipca Laboratories; target of Rs 1030: Motilal Oswal

Broker’s Call: Ipca Laboratories (Buy)

Ipca Laboratories Ltd up for third consecutive session

Movers & Shakers: Stocks that will see action this week

Hold Ipca Laboratories : target of Rs 1080: Sharekhan

IPCA Labs: Growth outlook primed by domestic business

Ipca Laboratories Ltd slips for fifth straight session

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock